Genedata has announced Genedata Biologics 2.0, its enterprise data management solution for end-to-end biologics R&D activities spanning antibody screening, protein engineering, and biologics production. Version 2.0 provides new protein production modules supporting the full biologics production process, including molecule definition and cloning, expression, purification, analytics, and quality control. This new functionality serves the needs of biologics discovery and protein sciences as well as cell culture and bioprocess development, biopharmaceutical development, protein technologies, and protein supply departments. Protein production modules may be used alone or with existing screening and engineering modules.
Genedata Biologics is a fully integrated data management platform for all biologics molecules, samples, analytics and assay data. The system can be used for the production of therapeutic antibodies and proteins, as well as tool proteins, such as antigens. Based on client-server architecture, Genedata Biologics features an interactive and intuitive web-based interface, which allows users to easily access, manage, analyse, and share information at all stages of the protein production process. While Genedata Biologics provides extensive built-in business logic, it can be configured to address corporate-specific workflows and standards.
The system handles complex workflows in a division-of-labour environment and provides tailored functionalities for facilitating sample and data handovers between sites and groups. Different groups along the protein production process use the system to access data for daily work and for registering experimental results to support downstream activities.